Weiwei Yu

618 total citations
15 papers, 434 citations indexed

About

Weiwei Yu is a scholar working on Molecular Biology, Hepatology and Cancer Research. According to data from OpenAlex, Weiwei Yu has authored 15 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Hepatology and 4 papers in Cancer Research. Recurrent topics in Weiwei Yu's work include Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Liver Disease Diagnosis and Treatment (2 papers) and Cancer, Lipids, and Metabolism (2 papers). Weiwei Yu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Liver Disease Diagnosis and Treatment (2 papers) and Cancer, Lipids, and Metabolism (2 papers). Weiwei Yu collaborates with scholars based in China, United States and United Kingdom. Weiwei Yu's co-authors include Changsui Zhao, Beicheng Sun, Huichao Chen, Xuewen Tao, Haitian Zhang, Guangyan Zhangyuan, Jincheng Wang, Wenjie Zhang, Yin Yin and Liansheng Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Immunity and Oncogene.

In The Last Decade

Weiwei Yu

14 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiwei Yu China 11 191 105 71 65 63 15 434
Yuanxin Liang United States 11 152 0.8× 68 0.6× 73 1.0× 24 0.4× 30 0.5× 35 364
Zhiying Shao China 12 174 0.9× 69 0.7× 95 1.3× 117 1.8× 30 0.5× 38 493
Xin Yan China 11 139 0.7× 85 0.8× 123 1.7× 16 0.2× 36 0.6× 37 450
Yijun Wang China 17 509 2.7× 295 2.8× 223 3.1× 27 0.4× 66 1.0× 32 894
Chengcheng Liao China 13 268 1.4× 77 0.7× 102 1.4× 35 0.5× 28 0.4× 40 545
Xirui Liu China 9 259 1.4× 237 2.3× 47 0.7× 8 0.1× 31 0.5× 13 456
Ladan Zolfaghari United States 7 178 0.9× 69 0.7× 120 1.7× 57 0.9× 16 0.3× 9 381
Haofan Wang China 10 186 1.0× 114 1.1× 97 1.4× 35 0.5× 18 0.3× 19 392

Countries citing papers authored by Weiwei Yu

Since Specialization
Citations

This map shows the geographic impact of Weiwei Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Yu more than expected).

Fields of papers citing papers by Weiwei Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiwei Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Yu. The network helps show where Weiwei Yu may publish in the future.

Co-authorship network of co-authors of Weiwei Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Weiwei Yu. A scholar is included among the top collaborators of Weiwei Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiwei Yu. Weiwei Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Xia, Anliang, Wenwen Yuan, Qiang Wang, et al.. (2022). The cancer-testis lncRNA lnc-CTHCC promotes hepatocellular carcinogenesis by binding hnRNP K and activating YAP1 transcription. Nature Cancer. 3(2). 203–218. 73 indexed citations
3.
Yu, Weiwei, Jianbo He, Fei Wang, et al.. (2022). NR4A1 mediates NK‐cell dysfunction in hepatocellular carcinoma via the IFN‐γ/p‐STAT1/IRF1 pathway. Immunology. 169(1). 69–82. 17 indexed citations
4.
Yu, Weiwei, et al.. (2021). The value of PIVKA-Ⅱ versus AFP for the diagnosis and detection of postoperative changes in hepatocellular carcinoma. SHILAP Revista de lepidopterología. 4(2). 77–81. 12 indexed citations
5.
Zhang, Wenjie, Guangyan Zhangyuan, Fei Wang, et al.. (2021). The zinc finger protein Miz1 suppresses liver tumorigenesis by restricting hepatocyte-driven macrophage activation and inflammation. Immunity. 54(6). 1168–1185.e8. 59 indexed citations
6.
Zhang, Haitian, Yuanyuan Sun, Guangyan Zhangyuan, et al.. (2020). PTPROt aggravates inflammation by enhancing NF-κB activation in liver macrophages during nonalcoholic steatohepatitis. Theranostics. 10(12). 5290–5304. 27 indexed citations
7.
Wang, Jincheng, Rao Fu, Xuewen Tao, et al.. (2020). A radiomics-based model on non-contrast CT for predicting cirrhosis: make the most of image data. Biomarker Research. 8(1). 47–47. 40 indexed citations
8.
Zhangyuan, Guangyan, Fei Wang, Haitian Zhang, et al.. (2019). VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR–PI3K–AKT pathway. Oncogene. 39(6). 1213–1230. 58 indexed citations
9.
Zhang, Wenjie, Fei Wang, Guangyan Zhangyuan, et al.. (2019). Differences in the prognostic value of tumor size on hepatocellular cancer‐specific survival stratified by gender in a SEER population‐based study. United European Gastroenterology Journal. 7(7). 933–941. 12 indexed citations
10.
Zhang, Wenjie, Guangyan Zhangyuan, Jincheng Wang, et al.. (2019). Effect of lymph nodes count in node-positive gastric cancer. Journal of Cancer. 10(23). 5646–5653. 10 indexed citations
11.
Zhang, Yaoyun, Hongyue Liu, Weiwei Yu, et al.. (2018). Mouse β-Defensin 3, A Defensin Inhibitor of Both Its Endogenous and Exogenous Potassium Channels. Molecules. 23(6). 1489–1489. 3 indexed citations
12.
Yu, Weiwei, Weiqiang Lü, Guoliang Chen, et al.. (2017). Inhibition of histone deacetylases sensitizes EGF receptor‐TK inhibitor‐resistant non‐small‐cell lung cancer cells to erlotinib in vitro and in vivo. British Journal of Pharmacology. 174(20). 3608–3622. 32 indexed citations
13.
Su, Hui, et al.. (2015). Design, synthesis and anticancer activities of novel otobain derivatives. Organic & Biomolecular Chemistry. 14(1). 277–287. 15 indexed citations
14.
Chen, Huichao, Changsui Zhao, & Weiwei Yu. (2013). Calcium-based sorbent doped with attapulgite for CO2 capture. Applied Energy. 112. 67–74. 66 indexed citations
15.
Zhang, Minghao, Xinyin Chen, Niobe Way, et al.. (2011). The association between infants’ self-regulatory behavior and MAOA gene polymorphism. Developmental Science. 14(5). 1059–1065. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuanxin Liang Breakdown of academic impact, for papers by Zhiying Shao Breakdown of academic impact, for papers by Xin Yan Breakdown of academic impact, for papers by Yijun Wang Breakdown of academic impact, for papers by Chengcheng Liao Breakdown of academic impact, for papers by Xirui Liu Breakdown of academic impact, for papers by Ladan Zolfaghari Breakdown of academic impact, for papers by Haofan Wang
Rankless by CCL
2026